ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,424,000 | +35.2% | 8,274 | -1.4% | 0.08% | +40.4% |
| Q2 2021 | $1,053,000 | -26.1% | 8,389 | -20.1% | 0.06% | -29.6% |
| Q1 2021 | $1,424,000 | +72.8% | 10,503 | +63.1% | 0.08% | +37.3% |
| Q4 2020 | $824,000 | -58.7% | 6,441 | -63.6% | 0.06% | -9.2% |
| Q3 2020 | $1,994,000 | -34.1% | 17,718 | -44.2% | 0.06% | -16.7% |
| Q2 2020 | $3,024,000 | +102.7% | 31,737 | +91.2% | 0.08% | +100.0% |
| Q1 2020 | $1,492,000 | +69.0% | 16,599 | -0.3% | 0.04% | +225.0% |
| Q4 2019 | $883,000 | – | 16,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |